Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

30
Number of overlapping holdings
13.4%
% of IBB's 261 holdings also in IDNA
65.2%
% of IDNA's 51 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBB |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
REGENERON PHARMACEUTICALS | 7.3% | 4.0% | 4.0% | |
BIONTECH SE SPONSORED ADR | 2.0% | 4.0% | 2.0% | |
INCYTE CORP | 1.3% | 4.2% | 1.3% | |
MODERNA, INC. | 1.2% | 3.6% | 1.2% | |
EXELIXIS INC | 1.1% | 4.8% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IDNA
GILEAD SCIENCES INC | 10.6% | |
AMGEN INC | 9.6% | |
VERTEX PHARMACEUTICALS INC | 8.7% | |
IQVIA HOLDINGS INC | 3.4% | |
REGENERON PHARMACEUTICALS | 3.3% | |
ALNYLAM PHARMACEUTICALS INC | 3.1% | |
ARGENX SE ADR | 2.7% | |
METTLER-TOLEDO INTERNATIONAL | 2.6% | |
WATERS CORP | 2.3% | |
BIOGEN IDEC INC | 2.1% |
IBB Underweight Relative to IDNA
BEIGENE, LTD. | -5.5% | |
SANOFI-AVENTIS | -5.4% | |
ROCHE HOLDING LTD | -5.3% | |
GSK PLC | -5.1% | |
ASTRAZENECA PLC | -5.1% | |
GENMAB A/S | -4.9% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.6% | |
SPRINGWORKS THERAPEUTICS, INC. | -4.5% | |
MERCK & CO. INC. | -4.1% | |
EXELIXIS INC | -3.7% |